GlassScriptPhysician profile
Constantine Francis Harris
NPI 1720077548
$6,145.66
in general payments reported to CMS, 2019-2025
35 companies · $2,634 in 2025
The $2,634 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $271 · 2021: $727 · 2022: $627 · 2023: $609 · 2024: $837 · 2025: $2,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,109 · Travel and Lodging: $1,887 · Education: $83.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,108.64 |
| Travel and Lodging | $1,886.53 |
| Education | $83.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,620.97 | 2020-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $580.11 | 2019-2023 | Xtandi |
| Abbvie INC. | $579.27 | 2019-2025 | |
| Janssen Biotech, INC. | $486.18 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $258.40 | 2021-2024 | |
| Urogen Pharma, INC. | $201.07 | 2022-2024 | Jelmyto |
| Sumitomo Pharma America, INC. | $150.13 | 2023-2025 | Gemtesa, Orgovyx |
| 180 Medical, INC. | $145.39 | 2022-2024 | Gentlecath |
| Myovant Sciences INC. | $114.33 | 2021-2022 | |
| Coloplast Corp | $82.76 | 2021-2024 | Speedicath |
| Bluewind Medical | $81.96 | 2024 | Revi |
| Neotract INC. | $80.24 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $79.15 | 2019-2025 | |
| Axonics, INC. | $74.36 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $72.69 | 2024-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $47.22 | 2023 | |
| Urovant Sciences INC | $44.78 | 2022 | |
| Progenics Pharmaceuticals, INC. | $43.19 | 2023 | Pylarify |
| Clarus Therapeutics INC. | $37.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $36.98 | 2022-2023 | Lynparza |
| Merck Sharp & Dohme LLC | $32.06 | 2021-2024 | Keytruda |
| Tolmar, INC. | $30.86 | 2024 | |
| Medtronic, INC. | $29.81 | 2025 | Interstim |
| Tempus Ai, INC | $29.66 | 2024 | |
| Procept Biorobotics Corporation | $29.65 | 2025 | |
| Convatec INC. | $27.96 | 2022 | |
| Mission Pharmacal Company | $26.82 | 2019-2020 | |
| Endo USA, INC. | $17.66 | 2024 | Xiaflex |
| Intuitive Surgical, INC. | $16.99 | 2024 | |
| Medtronic USA, INC. | $16.80 | 2020 | |
| Boston Scientific Corporation | $15.49 | 2025 | Axonics |
| Blue Earth Diagnostics | $14.75 | 2021 | |
| Dentsply Ih INC. | $14.32 | 2021 | |
| Foundation Medicine, INC. | $14.06 | 2023 | |
| Endo Pharmaceuticals INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.